Close

Analyst Ratings for Immuneering Corporation (IMRX)

IMRX Rating Summary

IMRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IMRX
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $18.00 (+157.5%) * Over Last 12-Mos
Rating Score: 8.8 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/19/2023 Mizuho Securities Mara Goldstein Upgrade Buy
(Neutral)
20.00
(10.00)
12.19
(6.99)
-42.66% Details
4/19/2023 Morgan Stanley Jeffrey Hung Upgrade Equalweight
(Underweight)
14.00
(5.00)
12.19
(6.99)
-42.66% Details
Like IMRX Ratings? Also take a look at TEVA, RAIN, VECT, MGTX

IMRX Ratings News